| Association of biotin ingestion with performance of hormone and nonhormone assays in healthy adults D Li, A Radulescu, RT Shrestha, M Root, AB Karger, AA Killeen, ... Jama 318 (12), 1150-1160, 2017 | 157 | 2017 |
| Neuropsychiatric manifestations of thyroid disease AZ Feldman, RT Shrestha, JV Hennessey Endocrinology and Metabolism Clinics 42 (3), 453-476, 2013 | 121 | 2013 |
| Acute and subacute, and Riedel’s thyroiditis KR Feingold, B Anawalt, A Boyce, G Chrousos, WW de Herder, ... Endotext, 2000 | 57* | 2000 |
| Correlation between histological diagnosis and mutational panel testing of thyroid nodules: a two-year institutional experience RT Shrestha, MR Evasovich, K Amin, A Radulescu, TS Sanghvi, ... Thyroid 26 (8), 1068-1076, 2016 | 45 | 2016 |
| Cytologic subclassification of atypia of undetermined significance may predict thyroid nodules more likely to be malignant at surgery RT Shrestha, JV Hennessey Diagnostic Cytopathology 44 (6), 492-498, 2016 | 35 | 2016 |
| Multiple mutations detected preoperatively may predict aggressive behavior of papillary thyroid cancer and guide management—a case report RT Shrestha, A Karunamurthy, K Amin, YE Nikiforov, ML Caramori Thyroid 25 (12), 1375-1378, 2015 | 30 | 2015 |
| Systematic review and meta-analysis of the impact of noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) on cytological diagnosis and thyroid … D Ruanpeng, W Cheungpasitporn, C Thongprayoon, JV Hennessey, ... Endocrine Pathology 30, 189-200, 2019 | 21 | 2019 |
| Thyroid nodules over 4 cm do not have higher malignancy or benign cytology false-negative rates M Kizilgul, R Shrestha, A Radulescu, MR Evasovich, LA Burmeister Endocrine 66, 249-253, 2019 | 20 | 2019 |
| Adverse event reporting in patients treated with thyroid hormone extract RT Shrestha, A Malabanan, BR Haugen, EG Levy, JV Hennessey Endocrine Practice 23 (5), 566-575, 2017 | 12 | 2017 |
| Acute, Subacute and Riedel’s Thyroiditis. In Endotext [Internet] RT Shrestha, J Hennessey MDText. com, Inc.,, 2015 | 12 | 2015 |
| Duration and onset of action of high dose U‐500 regular insulin in severely insulin resistant subjects with type 2 diabetes RT Shrestha, AF Kumar, A Taddese, AA Khowaja, A Moheet, E Olawsky, ... Endocrinology, Diabetes & Metabolism 1 (4), e00041, 2018 | 8 | 2018 |
| Role of Relative Malnutrition in Exercise Hypogonadal Male Condition. K Zekarias, RT Shrestha Medicine and science in sports and exercise 51 (2), 234-236, 2019 | 7 | 2019 |
| Cytomorphology of noninvasive follicular thyroid neoplasm with papillary-like nuclear features and the impact of new nomenclature on molecular testing RT Shrestha, D Ruanpeng, JV Hennessey Medical Sciences 7 (2), 15, 2019 | 4 | 2019 |
| Endotext RT Shrestha, JV Hennessey, LJ De Groot, G Chrousos, K Dungan, ... | 4 | 2000 |
| Does an endocrinology subspecialty residency rotation enhance resident endocrine clinical knowledge? YM Miller-Chang, JL Gauer, L Butler, APJ Olson, RT Shrestha, ... BMC medical education 22 (1), 49, 2022 | 2 | 2022 |
| Impact of molecular testing on thyroid nodule neoplastic diagnosis, stratified by 4-cm size, in a surgical series RT Shrestha, M Kizilgul, M Shahi, K Amin, MR Evasovich, LA Burmeister Scientific reports 9 (1), 17861, 2019 | 2 | 2019 |
| Semiquantitative assessment of cytomorphologic features can predict mutation status of thyroid nodules with indeterminate cytologic diagnosis M Shahi, SJ Bloechl, RI Vogel, R Shrestha, HR Krigman, M Evasovich, ... Human pathology 93, 81-89, 2019 | 2 | 2019 |
| Use of a continuous glucose monitor for preoperative monitoring and treatment of hypoglycemia in a case of pancreatic neuroendocrine tumor RC Lyerla, A Bajaj, RT Shrestha AACE Clinical Case Reports 5 (4), e255-e258, 2019 | 2 | 2019 |
| Pharmacodynamics of 100 vs. 200 Units of U500 Regular Insulin in Obese Subjects with T2DM A Kumar, RT Shrestha, AS Taddese, A Moheet, A Khowaja, EA Olawsky, ... Diabetes 67 (Supplement_1), 2018 | 1 | 2018 |
| SUN-316 Rare Neuroendocrine Tumor Presenting with Nocturnal Seizures R Lyerla, R Shrestha Journal of the Endocrine Society 3 (Supplement_1), SUN-316, 2019 | | 2019 |
